| Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival J Kloepper, L Riedemann, Z Amoozgar, G Seano, K Susek, V Yu, ... Proceedings of the National Academy of Sciences 113 (16), 4476-4481, 2016 | 327 | 2016 |
| The role of CXC chemokine receptors 1–4 on immune cells in the tumor microenvironment KH Susek, M Karvouni, E Alici, A Lundqvist Frontiers in immunology 9, 2159, 2018 | 192 | 2018 |
| Bone marrow laminins influence hematopoietic stem and progenitor cell cycling and homing to the bone marrow KH Susek, E Korpos, J Huppert, C Wu, I Savelyeva, F Rosenbauer, ... Matrix Biology 67, 47-62, 2018 | 48 | 2018 |
| Total skin electron beam therapy as part of multimodal treatment strategies for primary cutaneous T-cell lymphoma K Elsayad, KH Susek, HT Eich Oncology research and treatment 40 (5), 244-252, 2017 | 42 | 2017 |
| Outcome of COVID‐19 in multiple myeloma patients in relation to treatment KH Susek, C Gran, HG Ljunggren, E Alici, H Nahi European Journal of Haematology 105 (6), 751-754, 2020 | 18 | 2020 |
| A treatment planning study of prone vs. supine positions for locally advanced rectal carcinoma S Scobioala, C Kittel, P Niermann, H Wolters, KH Susek, U Haverkamp, ... Strahlentherapie und Onkologie 194 (11), 975-984, 2018 | 7 | 2018 |
| Generation of NK cells with chimeric-switch receptors to overcome PD1-mediated inhibition in cancer immunotherapy KH Susek, YA Schwietzer, M Karvouni, M Gilljam, M Keszei, A Hussain, ... Cancer Immunology, Immunotherapy, 1-15, 2022 | 5 | 2022 |
| Improved survival in multiple Myeloma patients undergoing autologous stem cell transplantation is entirely in the standard cytogenetic risk groups G Afram, KH Susek, K Uttervall, JD Wersäll, AK Wagner, V Luong, J Lund, ... European Journal of Haematology 106 (4), 546-554, 2021 | | 2021 |
| Radiation Therapy in Precursor T-Lymphoblastic Lymphoma/Leukemia G Reinartz, K Susek, M Stelljes Radiation Oncology, 1-9, 2017 | | 2017 |
